Dynamic Technology Lab’s Nektar Therapeutics NKTR Stock Holding History

Dynamic Technology Lab’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,464	Closed	-$166K	–	1376
2022 Q3	$166K	Buy	+3,464	New	+$206K	0.02%	981
2021 Q3	–	Sell	-1,434	Closed	-$369K	–	1351
2021 Q2	$369K	Buy	+1,434	New	+$397K	0.04%	700
2020 Q4	–	Sell	-856	Closed	-$213K	–	1229
2020 Q3	$213K	Buy	+856	New	+$269K	0.03%	791
2020 Q2	–	Sell	-751	Closed	-$201K	–	1212
2020 Q1	$201K	Buy	+751	New	+$232K	0.04%	776
2018 Q4	–	Sell	-837	Closed	-$766K	–	1200
2018 Q3	$766K	Buy	+837	New	+$714K	0.11%	323
2018 Q1	–	Sell	-228	Closed	-$205K	–	1260
2017 Q4	$205K	Buy	+228	New	+$135K	0.04%	870
2016 Q4	–	Sell	-1,597	Closed	-$412K	–	1069
2016 Q3	$412K	Buy	+1,597	New	+$411K	0.11%	323
2014 Q2	–	Sell	-980	Closed	-$178K	–	773
2014 Q1	$178K	Buy	+980	New	+$194K	0.1%	469

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Dynamic Technology Lab's NKTR Position: Q4 2022 in Review

Dynamic Technology Lab sold out of Nektar Therapeutics (NKTR) in Q4 2022, closing a stake of 3,464 shares — an estimated $166K sold.

Dynamic Technology Lab first reported a position in NKTR in Q1 2014 and held it in 8 quarters. The position peaked at $766K in Q3 2018. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.

Dynamic Technology Lab reported no remaining Nektar Therapeutics position as of Q4 2022 after selling out during the quarter.
Dynamic Technology Lab sold 3,464 Nektar Therapeutics shares in Q4 2022, an estimated $166K.
Dynamic Technology Lab first reported a position in Nektar Therapeutics in Q1 2014 and held it in 8 quarters.
Dynamic Technology Lab's Nektar Therapeutics position peaked at $766K in Q3 2018.
214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.

Based on Dynamic Technology Lab's 13F filing for Q4 2022, filed 14 Feb 2023.